First Trust Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,408
Closed -$272K 2541
2022
Q1
$272K Sell
10,408
-11,323
-52% -$321K ﹤0.01% 2392
2021
Q4
$861K Sell
21,731
-93,262
-81% -$4.25M ﹤0.01% 2113
2021
Q3
$5.75M Buy
114,993
+79,894
+228% +$4.36M 0.01% 1232
2021
Q2
$1.95M Sell
35,099
-24,437
-41% -$1.3M ﹤0.01% 1820
2021
Q1
$2.78M Buy
59,536
+13,376
+29% +$648K ﹤0.01% 1594
2020
Q4
$2.01M Buy
+46,160
New +$1.7M ﹤0.01% 1573

Other funds holding HCAT

First Trust Advisors's HCAT Position: Q2 2022 in Review

First Trust Advisors sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 10,408 shares — an estimated $272K sold.

First Trust Advisors first reported a position in HCAT in Q4 2020 and held it in 6 quarters. The position peaked at $5.75M in Q3 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

  • First Trust Advisors reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
  • First Trust Advisors sold 10,408 Health Catalyst shares in Q2 2022, an estimated $272K.
  • First Trust Advisors first reported a position in Health Catalyst in Q4 2020 and held it in 6 quarters.
  • First Trust Advisors's Health Catalyst position peaked at $5.75M in Q3 2021.
  • 179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on First Trust Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.